FDA Proposal for LDTs Risks Serious Consequences
Lab leaders say that the increased level of scrutiny proposed for such tests would be a detriment to innovation and patient care.
Author Information
Gail Dutton
Posts by the Author
Author Information
By Gail Dutton | Oct 18, 2023
Lab leaders say that the increased level of scrutiny proposed for such tests would be a detriment to innovation and patient care.